TABLE 2.
Titration of IDegLira and iGlarLixi
| FRC Therapy | Frequency | Recommended Dose Range, units | Self-Monitored Blood Glucose Level | Titration, units |
|---|---|---|---|---|
| IDegLira | Every 3–4 days | 10–50 | Above target range | +2* |
| Within target range | 0* | |||
| Below target range | −2* | |||
| iGlarLixi | Weekly | 15–60 | Above target range | +2 to +4† |
| Within target range | 0† | |||
| Below target range | −2 to −4† |
1 unit IDegLira contains 1 unit insulin degludec and 0.036 mg liraglutide.
1 unit iGlarLixi contains 1 unit insulin glargine and 0.33 µg lixisenatide.